MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$7,966,538
EPS
-$5.32
Unit: Dollar

Income Statement
2025-12-31
Research and development
1,834,506
General and administrative
6,257,477
Total operating expenses
8,091,983
Operating loss
-8,091,983
Interest income
125,445
Net loss
-7,966,538
Basic EPS
-5.32
Diluted EPS
-5.32
Basic Average Shares
1,498,793
Diluted Average Shares
1,498,793
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$7,966,538 Interest income$125,445 Operating loss-$8,091,983 Total operatingexpenses$8,091,983 General andadministrative$6,257,477 Research and development$1,834,506

Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals, Inc. (ACXP)